Autres langues Herantis Pharma Oyj

Actions

HRTIS

FI4000087861

Marché Fermé - Nasdaq Helsinki Autres places de cotation 13:46:37 26/04/2024			Varia. 5j.	Varia. 1 janv.
1,46 ^EUR	+2,10%		+1,74%	-7,30%

06/03	Herantis Pharma Oyj publie ses résultats pour l'exercice clos le 31 décembre 2023	CI
06/03	Transcript : Herantis Pharma Oyj, 2023 Earnings Call, Mar 06, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Herantis Pharma Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	06/03
Herantis Pharma Oyj: Managers' Transactions – Tone Kvåle	26/01
Herantis Pharma Oyj : Minutes of Herantis Pharma Plc’s extraordinary general meeting of shareholders November 17, 2023	17/11
Herantis Pharma Oyj : Notice to Convene Herantis Pharma Plc's Extraordinary General Meeting of Shareholders November 17, 2023	16/11
Herantis Pharma's Early-stage Study of Parkinson's Therapy Shows Positive Data; Stock Surges	25/10/23
Herantis Pharma Plc Announces Positive Topline Data from Phase 1a Clinical Trial of HER-096	25/10/23
Herantis Pharma Secures EUR4.5 Million Loan Waive-off From Business Finland	25/09/23
Herantis Pharma Oyj Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23
Herantis Pharma plc Announces First Healthy Volunteers Dosed in the Part 2 of the Her-096 Phase 1A Clinical Study	22/08/23
Herantis Pharma Plc's shares subscribed with option rights	19/07/23
Herantis Pharma Plc announcing start of recruitment of healthy volunteers for part 2 of the ongoing Phase 1a clinical study of HER-096	04/07/23
Herantis Pharma Plc Announces Start of Recruitment of Healthy Volunteers for Part 2 of the Ongoing Phase 1a Clinical Study of HER-096	04/07/23
Herantis Pharma Oyj: Managers' Transactions - Aki Prihti	20/06/23
Herantis Pharma Oyj: Managers' Transactions - Timo Veromaa	20/06/23
Herantis Pharma Oyj: Managers' Transactions - Frans Wuite	20/06/23
Herantis Pharma Oyj: Managers' Transactions - Tone Kvåle	09/06/23
Herantis Pharma Oyj: Managers' Transactions - Antti Vuolanto	09/06/23
Herantis Pharma Oyj: Managers' Transactions - Henri Huttunen	09/06/23
Herantis Pharma Plc's board decides on new option rights program for managing director, management team and other key personnel	02/06/23
Herantis Pharma to participate in Redeye Hosted Events: Investor Lunch and Redeye Growth Day	23/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Herantis Pharma Oyj

Actions

HRTIS

FI4000087861

Autres langues

Filtres